Pierre Winnepenninckx

Pierre Winnepenninckx serves as CEO at No deviation. No deviation operates in the pharmaceuticals sector with approximately 110.0 employees. The company is headquartered in Singapore.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • Our database includes 201,468 c suite-level executives.

Outlook WordPress.org Google Analytics Mobile Friendly Google Font API Bootstrap Framework Apache reCAPTCHA Google Tag Manager Hotjar

commissioning & qualification design development cgmp gdp training supplier audit qa qc management plan sop development engineering consultancy paperless validation pharmaceutical manufacturing commissioning qualification validation cqv regulatory compliance pharmaceutical engineering risk-based approach cgmp compliance process validation cleaning validation test plans installation qualification operational qualification performance qualification environmental monitoring quality assurance training services professional recruitment lean methodology digital audit readiness software validation gap analysis regulatory agencies patient safety process optimization troubleshooting project management iso compliance continuous improvement stakeholder communication clinical development gmp guidance medical devices regulation software implementation operational excellence audit support control strategies cgmp regulations bio-pharma solutions device qualification training programs client-orientated solutions quality management systems integrity in compliance healthcare standards pharmaceutical quality system risk assessment pharmaceuticals medical productivity

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Pierre Winnepenninckx in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at No deviation.

Pierre Winnepenninckx's Position in the MessageCEO Database

• •Pierre Winnepenninckx is 1 of 1 verified executive contact we track at No deviation.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •36 verified contacts work at pharmaceuticals companies in the 110.0 employee range (same size as No deviation).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Pierre Winnepenninckx directly?

Pierre Winnepenninckx's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at No deviation. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Pierre Winnepenninckx work for?

Pierre Winnepenninckx is CEO at No deviation, a company in the pharmaceuticals sector with 110.0 employees. The company is based in Singapore.

Can I pitch or sell to Pierre Winnepenninckx?

As CEO at No deviation, Pierre Winnepenninckx is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Pierre Winnepenninckx directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Pierre Winnepenninckx in?

Pierre Winnepenninckx works in the pharmaceuticals industry as CEO at No deviation. MessageCEO provides verified contact information for executives across all major industries.

Is Pierre Winnepenninckx's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Pierre Winnepenninckx's profile is kept up-to-date with the latest available information.

Last updated: July 27, 2026